Fibronostics Acquires Stone Clinical Laboratories
October 27, 2025
Fibronostics has completed the acquisition of Stone Clinical Laboratories, LLC, expanding its U.S. laboratory infrastructure to accelerate innovation in non-invasive diagnostics for metabolic and liver diseases (MASH/MASLD). The deal strengthens Fibronostics' R&D and testing capabilities, combining Stone Clinical's laboratory expertise with Fibronostics' proprietary LIVERFASt platform to support biomarker development, clinical validation, and collaborations with biopharma and healthcare partners.
- Buyers
- Fibronostics
- Targets
- Stone Clinical Laboratories, LLC
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
StatLab Medical Products Acquires Poly Scientific R&D
March 26, 2024
Medical Devices
StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.
-
FST Technical Services Acquires Criterion Labs
March 24, 2025
Industrial Services
FST Technical Services, a Phoenix/Chandler-based provider of testing, inspection, certification and commissioning services, has acquired Criterion Labs, Inc., a specialist in gas-line and laboratory testing. The acquisition expands FST's testing capabilities and geographic reach while strengthening its position serving semiconductor, technology and life-sciences customers.
-
Millstone Medical Outsourcing Acquires MycoScience
November 14, 2022
Healthcare Services
Millstone Medical Outsourcing, an Arlington Capital Partners portfolio company, has completed the acquisition of MycoScience, a Willington, Connecticut-based provider of medical device and pharmaceutical laboratory and environmental testing services. The acquisition adds advanced laboratory and regulatory testing capabilities to Millstone's post-manufacturing and aftermarket services, enabling more in-house testing, faster time to market, and expanded end-to-end offerings.
-
Quest Diagnostics Acquires Haystack Oncology
April 27, 2023
Healthcare Services
Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.
-
Castle Biosciences Acquires Cernostics
October 19, 2021
Healthcare Services
Castle Biosciences (Nasdaq: CSTL) has completed the acquisition of Cernostics, Inc., a Pittsburgh-based developer of the TissueCypher spatial biology and AI-driven image analysis platform, for approximately $30 million in initial consideration plus up to $50 million in performance-based milestones. The deal brings the TissueCypher Barrett's Esophagus Assay into Castle's portfolio, expanding the company's diagnostics capabilities into the gastrointestinal and oncology markets and adding an estimated ~$1 billion to Castle's U.S. TAM.
-
Quest Diagnostics Acquires Labtech Diagnostics
December 14, 2021
Healthcare Services
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.